fbpx

Find a Test

Our test portfolio includes JOINTstat (14-3-3eta protein test) for diagnosing and managing rheumatoid arthritis, and SPINEstat (Anti-14-3-3eta Multiplex) our first-in-class diagnostic test for axial spondyloarthritis.

14-3-3eta for Rheumatoid Arthritis – ASRs Available as a LDT at the Following Labs:

United States (US)

 

Quest Diagnostics

Test Name

Test Code

14-3-3eta Protein 91455

 

Labcorp

Test Name

Test Code

14-3-3eta Protein 504550
RheumAssure® (14-3-3eta, RF, anti-CCP) 504509
RAdx6 Profile (14-3-3eta, RF, anti-CCP, anti-CEP1, anti-Sa, anti-CarP) 520304
SeroNeg RAdx4 Profile (14-3-3eta, anti-CEP1, anti-Sa, anti-CarP) 520305
Rheumatoid Arthritis (RA) Profile with Reflex to SeroNeg RAdx4 (RF & anti-CCP, reflex to: 14-3-3eta, anti-CEP1, anti-Sa, anti-CarP) 520298

 

ARUP Laboratories

Test Name

Test Code

14-3-3eta Protein 3017890
Early and Established Rheumatoid Arthritis (RA) Panel (14-3-3eta, RF, anti-CCP) 3017891

 

 

 

COMING SOON

Sonic Healthcare USA

Divisions

Test Code

Clinical Pathology Laboratories Available Dec 2024
Sunrise Medical Laboratories Available Dec 2024
East Side Clinical Laboratory Available Dec 2024
Sonic Reference Laboratory Available Dec 2024
American Esoteric Laboratories Available Dec 2024
Pathology Laboratories Available Dec 2024
Clinical labs of Hawaii Available Dec 2024

Canada

In Canada, JOINTstat® is the Health Canada approved brand name for the 14-3-3η blood test. JOINTstat® is available from Dynacare for RA diagnosis and patient management. For additional information and instructions on how to order the test please contact the Dynacare National Specialty Service Support team at 1-888-988-1888 or email [email protected]

    Anti-14-3-3eta Multiplex for Axial Spondyloarthritis – ASRs Available as a LDT at the Following Lab:

    United States (US)

    Anti-14-3-3eta Multiplex is now available for early access in Knoxville, Tennessee through our partnership with New Day Diagnostics as a laboratory developed test (LDT).

    Expanded National Access Through Leading Labs in 2025

    Sign Up for Updates

    * indicates required
    Terms